Curriculum
8 Sections
68 Lessons
10 Weeks
Expand all sections
Collapse all sections
Module 1 Course Welcome
3
1.1
Course Introduction
1.2
Fintech Biotech innovation
1.3
The Journey
Module 2 Basic Concepts of Financing
11
2.1
Overview
2.2
Introduction to Financing
2.3
Revenues
2.4
Staged Financing
2.5
Financial Projections
2.6
Investor Input Staged Investing
2.7
Review
2.8
The Entrepreneur’s Perspective
2.9
The Investor’s Perspective
2.10
Dilution explained
2.11
Biotech Funding Properties
Module 3 Sources of Financing
10
3.1
Overview
3.2
Investor Input Challenges of Biotech Financing
3.3
Sources of Financing – an Overview
3.5
Founders, Family, Friends and Fools
3.6
Public Funding
3.7
Crowdfunding & Crowdinvesting
3.8
Angel Investments
3.9
Mid-Stage Sources of Financing
3.10
Late-Stage Sources of Financing
3.11
Review
Module 4 Funding Process
10
4.1
Overview
4.2
The Investment Process
4.4
Investor Input What Investors Are Looking For
4.5
Selecting an Investor
4.6
Screening Criteria of Investors
4.7
Founder Input What to Look For in an Investor
4.8
Structuring
4.9
Post-Investment Development
4.10
Post-Investment Development Founder Input Investor Relations
4.11
Review
Module 5 Valuation & Value Creation
15
5.1
Overview
5.2
Firm Value & Valuation
5.3
Valuation Challenges
5.4
Valuation Methods
5.5
Forecasting Cash Flows
5.6
DCF Method Introduction
5.7
Discouting & Terminal Value
5.8
Example DCF Explained
5.9
Valuation by Comparables Introduction
5.10
Example Comparables Explained
5.11
The VC Method Introduction
5.12
Example VC Method Explained
5.13
Valuation and its Consequences
5.14
Review
5.15
Investor Input How VCs Do Valuations
Module 6 Pitching & Closing a Financing Round
10
6.1
Overview
6.2
Pitching to Investors
6.3
Succeeding in Your Pitch
6.4
Expert Input Pitching Advice
6.5
Negotiating with Investors
6.6
Core Negotiation Concepts
6.7
Cultural Considerations
6.8
Expert Input Advice for Negotiating a Good Deal
6.9
Founder Input NPV Calculation for Negotiations
6.10
Review
Module 7 Exiting a Company
8
7.1
Overview
7.2
Exit The Ultimate Investor Goal
7.3
Investor Input What Determines a Biotech Exit
7.4
Common Exit Scenarios Trade Sale & Going Public
7.5
Founder Input A Founder’s Perspective on a Acquisition
7.6
Going Public
7.7
Founder Input Going Public
7.8
Review
Summary & Goodbye
1
8.1
Final Thoughts
Financial Innovation and Entrepreneurial finance
Search
This content is protected, please
login
and enroll in the course to view this content!
Modal title
Main Content